{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:44:06Z","timestamp":1793378646032,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.canlet.2024.216824","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T20:48:44Z","timestamp":1711140524000},"page":"216824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming"],"prefix":"10.1016","volume":"589","author":[{"given":"Ting","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxu","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3213-2967","authenticated-orcid":false,"given":"Meng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2024.216824_bib1","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1158\/2159-8290.CD-20-1312","article-title":"Paradigms on immunotherapy combinations with chemotherapy","volume":"11","author":"Salas-Benito","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2024.216824_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.canlet.2024.216824_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 challenges in cancer immunotherapy","volume":"52","author":"Hegde","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2024.216824_bib4","article-title":"Immunotherapy resistance in non-small-cell lung cancer: from mechanism to clinical strategies","volume":"14","author":"Zhou","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2024.216824_bib5","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S1470-2045(19)30388-2","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study","volume":"20","author":"Robert","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2024.216824_bib6","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.jtho.2021.05.001","article-title":"Five year survival update from KEYNOTE-010: pembrolizumab versus docetaxel for previously treated, programmed death-ligand 1-positive advanced NSCLC","volume":"16","author":"Herbst","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.canlet.2024.216824_bib7","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S1470-2045(19)30626-6","article-title":"Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial","volume":"20","author":"Kato","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2024.216824_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41416-018-0131-9","article-title":"Efficacy and safety of pembrolizumab in recurrent\/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012","volume":"119","author":"Mehra","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2024.216824_bib9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/2159-8290.CD-15-0283","article-title":"Loss of PTEN promotes resistance to T cell-mediated immunotherapy","volume":"6","author":"Peng","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2024.216824_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic beta-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.216824_bib11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","article-title":"Loss of IFN-gamma pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy","volume":"167","author":"Gao","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2024.216824_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2024.216824_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.canlet.2024.216824_bib14","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1172\/JCI69600","article-title":"Glutamine and cancer: cell biology, physiology, and clinical opportunities","volume":"123","author":"Hensley","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2024.216824_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216381","article-title":"CD155 and its receptors in cancer immune escape and immunotherapy","volume":"573","author":"Zhou","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216824_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216043","article-title":"CD8(+) T cell exhaustion and cancer immunotherapy","volume":"559","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216824_bib17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pharmthera.2018.11.004","article-title":"Altered cancer metabolism in mechanisms of immunotherapy resistance","volume":"195","author":"Ramapriyan","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2024.216824_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2024.216824_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.canlet.2024.216824_bib20","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2024.216824_bib21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cell.2017.09.019","article-title":"Lactate metabolism in human lung tumors","volume":"171","author":"Faubert","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2024.216824_bib22","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2174\/138161212799504902","article-title":"Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis","volume":"18","author":"Dhup","year":"2012","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.canlet.2024.216824_bib23","first-page":"119","article-title":"Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect","volume":"38","author":"San-Millan","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2024.216824_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1158\/2326-6066.CIR-18-0481","article-title":"Lactate-mediated acidification of tumor microenvironment induces apoptosis of liver-resident NK cells in colorectal liver metastasis","volume":"7","author":"Harmon","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.canlet.2024.216824_bib25","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.1901376116","article-title":"Enhanced oxidative phosphorylation in NKT cells is essential for their survival and function","volume":"116","author":"Kumar","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2024.216824_bib26","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.4049\/jimmunol.1300772","article-title":"Dendritic cell reprogramming by endogenously produced lactic acid","volume":"191","author":"Nasi","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2024.216824_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fonc.2018.00081","article-title":"Metabolic symbiosis and immunomodulation: how tumor cell-derived lactate may disturb innate and adaptive immune responses","volume":"8","author":"Morrot","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2024.216824_bib28","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1016\/j.bbadis.2017.08.030","article-title":"MDA-MB-231 breast cancer cells fuel osteoclast metabolism and activity: a new rationale for the pathogenesis of osteolytic bone metastases","volume":"1863","author":"Lemma","year":"2017","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.canlet.2024.216824_bib29","first-page":"4757","article-title":"Correlation of high lactate levels in human cervical cancer with incidence of metastasis","volume":"55","author":"Schwickert","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.216824_bib30","first-page":"409","article-title":"Correlation of high lactate levels in head and neck tumors with incidence of metastasis","volume":"150","author":"Walenta","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2024.216824_bib31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00432-003-0450-x","article-title":"Metabolic classification of human rectal adenocarcinomas: a novel guideline for clinical oncologists?","volume":"129","author":"Walenta","year":"2003","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.216824_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3892\/ijo.2012.1687","article-title":"Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target","volume":"42","author":"Hur","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2024.216824_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216179","article-title":"Glucose transporter 4: insulin response mastermind, glycolysis catalyst and treatment direction for cancer progression","volume":"563","author":"Chang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216824_bib34","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","article-title":"Lactate metabolism in human health and disease","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2024.216824_bib35","first-page":"212","article-title":"Linking tumor glycolysis and immune evasion in cancer: emerging concepts and therapeutic opportunities, Biochimica et biophysica acta","volume":"1868","author":"Ganapathy-Kanniappan","year":"2017","journal-title":"Rev. Cancer"},{"key":"10.1016\/j.canlet.2024.216824_bib36","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.semcancer.2022.11.007","article-title":"Role of LDH in tumor glycolysis: regulation of LDHA by small molecules for cancer therapeutics","volume":"87","author":"Sharma","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2024.216824_bib37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/bj1540405","article-title":"L-lactate transport in Ehrlich ascites-tumour cells","volume":"154","author":"Spencer","year":"1976","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2024.216824_bib38","volume":"vol. 2010","author":"Pinheiro","year":"2010"},{"key":"10.1016\/j.canlet.2024.216824_bib39","doi-asserted-by":"crossref","first-page":"11780","DOI":"10.3748\/wjg.v20.i33.11780","article-title":"Characterization of monocarboxylate transporter activity in hepatocellular carcinoma","volume":"20","author":"Alves","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.canlet.2024.216824_bib40","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1080\/15384101.2016.1175258","article-title":"The metabolic microenvironment of melanomas: prognostic value of MCT1 and MCT4","volume":"15","author":"Pinheiro","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2024.216824_bib41","article-title":"MCT4 promotes tumor malignancy in F98 glioma cells","volume":"2021","author":"Reuss","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2024.216824_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf6290","article-title":"ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation","volume":"7","author":"Yang","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2024.216824_bib43","article-title":"Functional status and spatial architecture of tumor-infiltrating CD8+T cells are associated with lymph node metastases in non-small cell lung cancer","volume":"21","author":"Yang","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2024.216824_bib44","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.canlet.2024.216824_bib45","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.canlet.2024.216824_bib46","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/sj.cdd.4401466","article-title":"Alterations of intracellular pH homeostasis in apoptosis: origins and roles","volume":"11","author":"Lagadic-Gossmann","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2024.216824_bib47","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1042\/BJ20151120","article-title":"The anti-tumour agent lonidamine is a potent inhibitor of the mitochondrial pyruvate carrier and plasma membrane monocarboxylate transporters","volume":"473","author":"Nancolas","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2024.216824_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-immunol-070621-030155","article-title":"Resistance mechanisms to anti-PD cancer immunotherapy","volume":"40","author":"Vesely","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2024.216824_bib49","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","article-title":"The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression","volume":"95","author":"Vaupel","year":"2019","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.canlet.2024.216824_bib50","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg's contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2024.216824_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100797","article-title":"Impact of cancer metabolism on therapy resistance - clinical implications","volume":"59","author":"Gon\u00e7alves","year":"2021","journal-title":"Drug Resist. Updates : Rev. Comment. Antimicrob.Anticancer Chemother."},{"key":"10.1016\/j.canlet.2024.216824_bib52","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell Metabol."},{"key":"10.1016\/j.canlet.2024.216824_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1091779","article-title":"The significance of glycolysis in tumor progression and its relationship with the tumor microenvironment","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2024.216824_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032606","article-title":"Modulating glycolysis to improve cancer therapy","volume":"24","author":"Chelakkot","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2024.216824_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216396","article-title":"Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy","volume":"575","author":"Luo","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216824_bib56","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Martinez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2024.216824_bib57","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1113\/JP278810","article-title":"Revisiting the Warburg effect: historical dogma versus current understanding","volume":"599","author":"Vaupel","year":"2021","journal-title":"J. Physiol."},{"key":"10.1016\/j.canlet.2024.216824_bib58","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/cac2.12348","article-title":"Pivotal roles of tumor-draining lymph nodes in the abscopal effects from combined immunotherapy and radiotherapy","volume":"42","author":"Liu","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.canlet.2024.216824_bib59","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1158\/0008-5472.CAN-20-3044","article-title":"HDAC11 regulates glycolysis through the LKB1\/AMPK signaling pathway to maintain hepatocellular carcinoma stemness","volume":"81","author":"Bi","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.216824_bib60","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41419-021-03596-w","article-title":"The fatty acid receptor CD36 promotes HCC progression through activating Src\/PI3K\/AKT axis-dependent aerobic glycolysis","volume":"12","author":"Luo","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2024.216824_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1013885","article-title":"Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy","volume":"10","author":"Xiao","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2024.216824_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100551","article-title":"Sulconazole induces PANoptosis by triggering oxidative stress and inhibiting glycolysis to increase radiosensitivity in esophageal cancer","volume":"22","author":"Liu","year":"2023","journal-title":"Mol. Cell. Proteomics : MCP"},{"key":"10.1016\/j.canlet.2024.216824_bib63","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ccell.2016.10.006","article-title":"Inhibition of the glycolytic activator PFKFB3 in endothelium induces tumor vessel normalization, impairs metastasis, and improves chemotherapy","volume":"30","author":"Cantelmo","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2024.216824_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216696","article-title":"Palmitoylation alters LDHA activity and pancreatic cancer response to chemotherapy","volume":"587","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216824_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216657","article-title":"Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer","volume":"587","author":"Zhao","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216824_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216285","article-title":"NUSAP1-LDHA-Glycolysis-Lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma","volume":"567","author":"Chen","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216824_bib67","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.canlet.2015.05.015","article-title":"Monocarboxylate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells","volume":"365","author":"Amorim","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216824_bib68","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1038\/s41467-019-10566-6","article-title":"Mechanistic basis of L-lactate transport in the SLC16 solute carrier family","volume":"10","author":"Bosshart","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.216824_bib69","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1038\/s41467-022-32521-8","article-title":"Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity","volume":"13","author":"Feng","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.216824_bib70","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cytogfr.2022.11.001","article-title":"Crosstalk between glucose metabolism, lactate production and immune response modulation","volume":"68","author":"Ye","year":"2022","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.canlet.2024.216824_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2022.1610350","article-title":"Cancer-associated stromal fibroblast-derived transcriptomes predict poor clinical outcomes and immunosuppression in colon cancer","volume":"28","author":"Wang","year":"2022","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.canlet.2024.216824_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.641978","article-title":"Evaluation of monocarboxylate transporter 4 (MCT4) expression and its prognostic significance in circulating tumor cells from patients with early stage non-small-cell lung cancer","volume":"9","author":"Markou","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2024.216824_bib73","doi-asserted-by":"crossref","first-page":"20159","DOI":"10.1073\/pnas.1918986117","article-title":"ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment","volume":"117","author":"Li","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2024.216824_bib74","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.32348","article-title":"Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack","volume":"77","author":"Fang","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2024.216824_bib75","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007349","article-title":"MCT4 blockade increases the efficacy of immune checkpoint blockade","volume":"11","author":"Babl","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2024.216824_bib76","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nchembio744","article-title":"Monocarboxylate transporter MCT1 is a target for immunosuppression","volume":"1","author":"Murray","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.canlet.2024.216824_bib77","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002305","article-title":"Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma","volume":"9","author":"Deng","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2024.216824_bib78","doi-asserted-by":"crossref","first-page":"713","DOI":"10.4149\/neo_2023_230711N362","article-title":"miR-124 delivered by BM-MSCs-derived exosomes targets MCT1 of tumor-infiltrating Treg cells and improves ovarian cancer immunotherapy","volume":"70","author":"Gao","year":"2023","journal-title":"Neoplasma"},{"key":"10.1016\/j.canlet.2024.216824_bib79","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3389\/fimmu.2019.01878","article-title":"Lactate induces pro-tumor reprogramming in intratumoral plasmacytoid dendritic cells","volume":"10","author":"Raychaudhuri","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2024.216824_bib80","doi-asserted-by":"crossref","first-page":"26682","DOI":"10.1021\/acsami.1c02404","article-title":"Glucose and triphenylphosphonium Co-modified redox-sensitive liposomes to synergistically treat glioma with doxorubicin and lonidamine","volume":"13","author":"Peng","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.canlet.2024.216824_bib81","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.lungcan.2018.10.016","article-title":"Targeting glucose and glutamine metabolism combined with radiation therapy in non-small cell lung cancer","volume":"126","author":"Meijer","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2024.216824_bib82","first-page":"497","article-title":"Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells","volume":"66","author":"Floridi","year":"1981","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2024.216824_bib83","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cmet.2020.12.003","article-title":"The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure","volume":"33","author":"Cluntun","year":"2021","journal-title":"Cell Metabol."},{"key":"10.1016\/j.canlet.2024.216824_bib84","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.semcancer.2022.09.007","article-title":"Tumor glycolysis, an essential sweet tooth of tumor cells","volume":"86","author":"Paul","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2024.216824_bib85","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ebiom.2019.03.068","article-title":"Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment","volume":"42","author":"Jiang","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.canlet.2024.216824_bib86","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cmet.2017.06.004","article-title":"Similarities and distinctions of cancer and immune metabolism in inflammation and tumors","volume":"26","author":"Andrejeva","year":"2017","journal-title":"Cell Metabol."},{"key":"10.1016\/j.canlet.2024.216824_bib87","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.canlet.2019.03.015","article-title":"Metabolic reprogramming of macrophages during infections and cancer","volume":"452","author":"Wang","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.216824_bib88","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13059-021-02308-z","article-title":"Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma","volume":"22","author":"Yu","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.canlet.2024.216824_bib89","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","article-title":"Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells","volume":"82","author":"Xiong","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2024.216824_bib90","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.cell.2023.11.022","article-title":"Metabolic regulation of homologous recombination repair by MRE11 lactylation","volume":"187","author":"Chen","year":"2024","journal-title":"Cell"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524002179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524002179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T02:26:47Z","timestamp":1713234407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524002179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":90,"alternative-id":["S0304383524002179"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216824","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"216824"}}